Psoriasis Global Market Report 2024

Description

“Psoriasis Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on psoriasis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for psoriasis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The psoriasis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Drug class: Interleukin Inhibitors; Corticosteroids; Anti-Inflammatory; Tumor Necrosis Factor Inhibitor
2) By Drug Types: Small molecules; Biologics
3) By Disease Indication: Plaque Psoriasis; Nail Psoriasis; Guttate Psoriasis; Pustular Psoriasis; Erythrodermic Psoriasis
4) By Route Of Administration: Oral; Tropical; Injectable
5) By Distribution Channel: Hospitals; Retail Pharmacies; E-Commerce
Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Novartis AG; Eli Lilly and Company; Celgene Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Psoriasis is a skin condition characterized by the development of a rash with itchy, scaly patches, typically affecting areas such as the knees, elbows, trunk, and scalp. The underlying cause is often related to an immune system dysfunction where infection-fighting cells mistakenly attack healthy skin cells.

The primary categories of drugs used to manage psoriasis include interleukin inhibitors, corticosteroids, anti-inflammatories, and tumor necrosis factor inhibitors. Corticosteroids are a group of steroid hormones produced by the adrenal cortex in vertebrates and can also be synthesized as medications. These drugs come in various forms, including small molecules and biologics, and are applied to treat different manifestations of the disease, such as plaque psoriasis, nail psoriasis, guttate psoriasis, pustular psoriasis, and erythrodermic psoriasis. They are administered via various routes, including oral, topical, and injectable methods and can be obtained through hospitals, retail pharmacies, and e-commerce channels.

The psoriasis market research report is one of a series of new reports from The Business Research Company that provides psoriasis market statistics, including psoriasis industry global market size, regional shares, competitors with a psoriasis market share, detailed psoriasis market segments, market trends, and opportunities, and any further data you may need to thrive in the psoriasis industry. This psoriasis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The psoriasis market size has grown rapidly in recent years. It will grow from $23.87 billion in 2023 to $26.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed during the historical period can be attributed to various factors, including advances in epidemiology, increased patient awareness and education regarding psoriasis, and improvements in healthcare infrastructure and access for those seeking treatment.

The psoriasis market size is expected to see rapid growth in the next few years. It will grow to $39.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The projected growth in the forecast period can be attributed to factors such as regulatory approvals for new treatments, evolving patient preferences, a growing aging population, increased awareness of psoriasis, and the introduction of innovative therapies. Prominent trends in this forecast period encompass advancements in research and development, the rise of biologics and targeted therapies, the emergence of oral small molecule therapies, the adoption of personalized medicine, the integration of telemedicine and digital health solutions, the promotion of patient-centric care models, the utilization of biosimilars, and the incorporation of artificial intelligence and machine learning in healthcare for psoriasis management.

The increasing prevalence of psoriasis patients is a driving force behind the growth of the psoriasis market. Psoriasis, a skin condition, is influenced by factors such as the immune system, genetics, and environmental factors. Over recent years, the surge in psoriasis cases can be primarily attributed to climate changes, elevated stress levels, and unhealthy lifestyles. The World Psoriasis Day consortium reports that a significant 2 to 3% of the global population, which translates to 125 million individuals, suffers from psoriasis. Consequently, the escalating number of psoriasis patients is expected to be a key driver for the growth of the psoriasis market in the foreseeable future.

The psoriasis market is poised for growth, thanks to the increasing geriatric population. This demographic, composed of individuals aged 65 years and older, is more prone to conditions like hypertension, diabetes, and elevated blood glucose levels, which can exacerbate psoriasis. According to the World Health Organization's October 2022 data, one in six individuals worldwide will be 60 or older by 2030, with the total population in this age group expected to reach 1.4 billion, up from 1 billion in 2020. The number of people aged 80 or older is predicted to triple to 426 million by 2050. Consequently, the rising geriatric population is a driving force behind the growth of the psoriasis market.

The high cost associated with psoriasis therapy is expected to act as a constraint on the market's growth over the forecast period. For instance, reported by WebMD, the use of disease-modifying antirheumatic medications (DMARD) for treating Psoriatic Arthritis (PsA) can cost between $1,500 and $2,000 annually. In the United States, a dermatologist office visit typically ranges from $150 to $200. Patent protections often limit access to more affordable alternative medications, contributing to the high cost of psoriasis therapy and subsequently hampering market growth.

An emerging trend in the psoriasis market is the use of combination therapy. Combination therapy involves the simultaneous use of two different psoriasis treatments. Combining drugs with distinct mechanisms of action (combination therapy) often results in more significant treatment effects compared to monotherapy (using a single drug). Studies indicate that combination therapy provides more effective relief from psoriasis symptoms and is associated with fewer side effects. An example of combination therapy for treating active Psoriatic Arthritis (PsA) is the combination of Taltz (ixekizumab) with methotrexate, a development by Eli Lilly and Company.

Major companies operating in the psoriasis market are intensifying their efforts to introduce innovative products and secure approval from regulatory agencies, aiming to maximize their market revenues. The drug development and approval process is intricate and time-consuming, requiring drug sponsors to navigate the regulatory framework and marketing pathways to ensure safety and effectiveness. As an illustration, in September 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for SPEVIGO, marking the first approved treatment for generalized pustular psoriasis (GPP) flare-ups in adults. SPEVIGO is a novel, highly selective antibody designed to inhibit the interleukin-36 receptor (IL-36R) activation, a pivotal component of an immune system signaling pathway linked to GPP development. GPP, characterized by periods of widespread eruptions of sterile pustules, is a rare and potentially life-threatening neutrophilic skin condition.

The process of approving psoriasis drugs has become more streamlined on a global scale, as evidenced by the increasing approvals of drugs for psoriasis in recent years. Some notable examples include the regulatory approval of SKYRIZI (risankizumab) for plaque psoriasis treatment in Japan and the Center for Drug Evaluation and Research's approval of Avsola (infliximab-axxq) for treating plaque psoriasis. This simplified drug approval process is expected to drive the psoriasis drugs market in the forecast period.

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline PLC, Incyte Pharmaceuticals Corp., LEO Pharmacy

North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the psoriasis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The psoriasis market consists of sales of Methotrexate, Ciclosporin, and Acitretin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r9222

1. Executive Summary

2. Psoriasis Market Characteristics

3. Psoriasis Market Trends And Strategies

4. Psoriasis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Psoriasis Market Size and Growth

5.1. Global Psoriasis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Psoriasis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Psoriasis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Psoriasis Market Segmentation

6.1. Global Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Small molecules
Biologics
6.2. Global Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Interleukin Inhibitors
Corticosteroids
Anti-Inflammatory
Tumor Necrosis Factor Inhibitor
6.3. Global Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Plaque Psoriasis
Nail Psoriasis
Guttate Psoriasis
Pustular Psoriasis
Erythrodermic Psoriasis
6.4. Global Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Tropical
Injectable
6.5. Global Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Retail Pharmacies
E-Commerce

7. Psoriasis Market Regional And Country Analysis

7.1. Global Psoriasis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Psoriasis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Psoriasis Market

8.1. Asia-Pacific Psoriasis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Psoriasis Market

9.1. China Psoriasis Market Overview
9.2. China Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Psoriasis Market

10.1. India Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Psoriasis Market

11.1. Japan Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Psoriasis Market

12.1. Australia Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Psoriasis Market

13.1. Indonesia Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Psoriasis Market

14.1. South Korea Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Psoriasis Market

15.1. Western Europe Psoriasis Market Overview
15.2. Western Europe Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Psoriasis Market

16.1. UK Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Psoriasis Market

17.1. Germany Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Psoriasis Market

18.5. France Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Psoriasis Market

19.9. Italy Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Psoriasis Market

20.13. Spain Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Psoriasis Market

21.1. Eastern Europe Psoriasis Market Overview
21.2. Eastern Europe Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Psoriasis Market

22.1. Russia Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Psoriasis Market

23.1. North America Psoriasis Market Overview
23.2. North America Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Psoriasis Market

24.1. USA Psoriasis Market Overview
24.2. USA Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Psoriasis Market

25.1. Canada Psoriasis Market Overview
25.2. Canada Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Psoriasis Market

26.1. South America Psoriasis Market Overview
26.2. South America Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Psoriasis Market

27.1. Brazil Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Psoriasis Market

28.1. Middle East Psoriasis Market Overview
28.2. Middle East Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Psoriasis Market

29.1. Africa Psoriasis Market Overview
29.2. Africa Psoriasis Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Psoriasis Market Competitive Landscape And Company Profiles

30.1. Psoriasis Market Competitive Landscape
30.2. Psoriasis Market Company Profiles
- 30.2.1. AbbVie Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Eli Lilly and Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Celgene Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Psoriasis Market Competitive Benchmarking

32. Global Psoriasis Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Psoriasis Market

34. Psoriasis Market Future Outlook and Potential Analysis

34.1 Psoriasis Market In 2028 - Countries Offering Most New Opportunities
34.2 Psoriasis Market In 2028 - Segments Offering Most New Opportunities
34.3 Psoriasis Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer